Trained at Duke University and Fred Hutchinson Cancer Research Center – Dr. Gulsan specializes in allogenic bone marrow transplantation with a focus on related donor cases.
Dr. Dror Levin specializes in pediatric hematology and oncology, with a focus on bone marrow transplantation and sarcoma treatment at Sourasky Medical Center.
Dr. Seehirunwong specializes in interpreting medical imaging tests and consulting on patient care at Intrarat Hospital.
Dr. Yair specializes in hematology with a focus on chronic lymphocytic leukemia – recognized with multiple awards for his research and clinical excellence.
Professor Hasan Atilla Ozkan specializes in allogeneic bone marrow transplants at VM Medical Park Pendik Hospital, with extensive training and leadership in hematology.
Dr. Alemdar specializes in allogenic bone marrow transplants at Medical Park Antalya Hospital Complex, with extensive training in medical oncology and internal medicine.
Dr. Danylesko specializes in allogenic bone marrow transplantation at Sheba Medical Center, one of Israel's top hospitals.
Dr. Abraham Avigdor, MD, is Director of the Institute of Hematology and Co‑Director of the Hematology & Bone Marrow Transplantation Division at Sheba Medical Center. He is an international leader in lymphoma, CAR‑T, and advanced hemato‑oncology with more than 35 years of experience. His clinical focus includes lymphomas, multiple myeloma, and complex blood cancers.
He is a pioneer in CAR‑T integration. He leads cellular therapy and bone marrow transplantation programs (autologous and allogeneic). He also advances stem cell therapies and precision diagnostics, including PET/CT‑based prognostics. His work includes immunotherapy and targeted regimens and the development of innovative, data‑driven protocols.
He collaborates with LYSA, EMCL, and international PET groups. He has authored more than 130 publications. Key roles include Founder and President of the Israeli Lymphoma Working Group, former Chair of the Israeli Lymphoma Study Group, and Senior Lecturer at Tel Aviv University. Education: MD, Ben‑Gurion University; residency, Sheba Medical Center; postdoctoral fellowship, Weizmann Institute. Awards include the Knesset Prize, the Israeli Ministry of Health Award, and the Sackler Prize.
Prof. Elad Jacoby, MD, heads the Pediatric Cell Therapy Center at Sheba Medical Center. He is the Medical Director of the Advanced Biotherapy Center. He is a pioneer of pediatric CAR T‑cell therapy in Israel. He led one of the first national leukemia programs. He has almost 20 years of clinical and research experience.
He specializes in CAR T‑cell therapy, bone marrow and stem cell transplantation, and high‑risk pediatric leukemias and lymphomas. He leads international clinical trials and has authored over 240 publications. His collaborations include Johns Hopkins Hospital and the U.S. National Cancer Institute. He is an Associate Professor at Tel Aviv University. He received his MD from Tel Aviv University, completed residency at Sheba Medical Center, and fellowships at Johns Hopkins and the National Cancer Institute. He is board‑certified in Pediatrics and in Pediatric Hematology and Oncology. He serves on the IBFM CAR T‑Cell Taskforce and the Sheba Institutional Review Board. He leads the integration of CAR T‑cell therapy with transplantation.
Dr. Irina Zaidman specializes in pediatric bone marrow transplants at Hadassah Medical Center, with training from top institutions worldwide.
3,500+ bone marrow transplants – Dr. Stepensky is recognized by Forbes as one of the best doctors, specializing in children's rare blood cancer diseases.
Professor Zila Zuckerman is a specialist in hematology and transplantology at Rambam Medical Center.
Dr. Iris Kventsel, MD, is a pediatric hemato-oncologist and bone marrow transplant (BMT) specialist at Sheba Medical Center. She is an attending physician in the Pediatric Hemato-Oncology and BMT Division at the Edmond and Lily Safra Children’s Hospital. Her clinical focus is pediatric sarcomas, including Ewing sarcoma, osteosarcoma, and rhabdomyosarcoma.
She provides multidisciplinary care, including transplant and cellular therapies. She also uses current chemotherapy protocols and targeted therapies for complex childhood cancers.
Her research focuses on genetic cancer predisposition, including Li-Fraumeni syndrome, and cancer susceptibility genes. She has published in pediatric oncology, stem cell biology, and surgical oncology (HIPEC). She is on the academic staff at Tel Aviv University. Education: MD, Technion; Pediatrics residency, Assaf HaRofeh; Pediatric Hemato-Oncology fellowship, Sheba.